[go: up one dir, main page]

WO2009064156A8 - Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice - Google Patents

Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice Download PDF

Info

Publication number
WO2009064156A8
WO2009064156A8 PCT/MY2007/000079 MY2007000079W WO2009064156A8 WO 2009064156 A8 WO2009064156 A8 WO 2009064156A8 MY 2007000079 W MY2007000079 W MY 2007000079W WO 2009064156 A8 WO2009064156 A8 WO 2009064156A8
Authority
WO
WIPO (PCT)
Prior art keywords
composition obtained
labisia pumila
novel composition
hepatoprotective activity
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MY2007/000079
Other languages
English (en)
Other versions
WO2009064156A1 (fr
Inventor
Ghulam Nabi Qazi
Sarang Bani
Anpurna Kaul
Anjali Pandey
Kiranjeet Kour
Surrinder Koul
Bishan Dutt Gupta
Pyarelal Sangwan
Ravinder Kumar Raina
Rajendran Manickavasagar
Balkrishnan Chandan
Prashant Singh Chauhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
HOLISTA BIOTECHNOLOGY Sdn Bhd
Original Assignee
Council of Scientific and Industrial Research CSIR
HOLISTA BIOTECHNOLOGY Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR, HOLISTA BIOTECHNOLOGY Sdn Bhd filed Critical Council of Scientific and Industrial Research CSIR
Priority to PCT/MY2007/000079 priority Critical patent/WO2009064156A1/fr
Publication of WO2009064156A1 publication Critical patent/WO2009064156A1/fr
Anticipated expiration legal-status Critical
Publication of WO2009064156A8 publication Critical patent/WO2009064156A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne d'une manière générale un procédé permettant de préparer un extrait de plante et, plus précisément, le procédé de préparation de l'extrait de Labisia pumila hydrosoluble. L'invention concerne également une composition ou une préparation pharmaceutique obtenue à partir d'extrait de Libisia pumila destiné à la préparation d'un médicament se rapportant à l'activité hépatoprotectrice.
PCT/MY2007/000079 2007-11-15 2007-11-15 Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice Ceased WO2009064156A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/MY2007/000079 WO2009064156A1 (fr) 2007-11-15 2007-11-15 Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2007/000079 WO2009064156A1 (fr) 2007-11-15 2007-11-15 Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice

Publications (2)

Publication Number Publication Date
WO2009064156A1 WO2009064156A1 (fr) 2009-05-22
WO2009064156A8 true WO2009064156A8 (fr) 2011-11-24

Family

ID=40638916

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MY2007/000079 Ceased WO2009064156A1 (fr) 2007-11-15 2007-11-15 Nouvelle composition obtenue à partir d'extrait de labisia pumila pour activité hépaprotectrice

Country Status (1)

Country Link
WO (1) WO2009064156A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010147449A1 (fr) * 2009-06-16 2010-12-23 Holista Biotech Sdn. Bhd. Activité adaptogène d'un extrait de labisia pumila
MY170724A (en) 2012-01-27 2019-08-27 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract

Also Published As

Publication number Publication date
WO2009064156A1 (fr) 2009-05-22

Similar Documents

Publication Publication Date Title
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2007090393A3 (fr) Préparation pharmaceutique
WO2009039843A3 (fr) Extrait de plantes de cannabis à faible thc pour le traitement de maladies
WO2009125964A3 (fr) Composition comprenant un polysaccharide extrait de panax ginseng destinée à la prévention et au traitement de maladies hépatiques
WO2010049454A3 (fr) Composition antimicrobienne tirée de copépodes
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
WO2008113912A3 (fr) Nouvelles compositions cosmetiques et/ ou pharmaceutiques et leurs applications
WO2008001325A3 (fr) Compositions phytothérapeutiques destinées au traitement de maladies de la cavité buccale
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2007097770A8 (fr) Comprimés de succinate de métoprolol er et méthodes pour leur préparation
WO2009059755A3 (fr) Nouveaux conjugués de neurturine pour une utilisation pharmaceutique
WO2009051417A3 (fr) Dérivés de lactame phénanthrène présentant une activité anticancéreuse et procédé de préparation de ceux-ci
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2011064558A3 (fr) Composition pharmaceutique
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
WO2008081268A3 (fr) Compositions pharmaceutiques d'entacapone
WO2007002666A3 (fr) Compositions pharmaceutiques et therapeutiques derivees d'une plante garcinia mangostana l
WO2007100668A3 (fr) Promédicaments antidépresseurs
WO2006078699A3 (fr) Compositions pour soins buccaux derivees de la famille labiatae
EP2003988A4 (fr) Composition à base d'extraits de plantes naturelles pour la prévention et le traitement d'hyperlipidémie et de l'accident cérébrovasculaire, thé naturel en contenant comme principe actif et procédé de préparation du thé naturel
WO2009041786A3 (fr) Composition pharmaceutique comprenant des inhibiteurs de molécule d'adhérence cellulaire isolée de piper longum pour la prévention et le traitement de maladies inflammatoires

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07834526

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 4687/DELNP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: PI 2010002279

Country of ref document: MY

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31.08.2010)

122 Ep: pct application non-entry in european phase

Ref document number: 07834526

Country of ref document: EP

Kind code of ref document: A1